Ander Pereira

Mr. Ander Pereira


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2016 in Letters in Drug Design & Discovery
Verified
Journal Article
Closed access
WLWillian E.A. de Lima
Willian E.A. de Lima
APAnder Pereira
Ander Pereira
ACAlexandre De Castro
Alexandre De Castro
ECElaine F.F. da Cunha
Elaine F.F. da Cunha
TRTeodorico C. Ramalho
Teodorico C. Ramalho
Neurotoxic organophosphate compounds (OP) are toxic and acetylcholinesterase (AChE) inhibitors are widely used as insecticides and pesticides in agriculture. This is a key enzyme in the search for new strategies for poisoning treatment by means of pesticides and insecticides. The standard OP intoxication treatment involves the administration of an anticholinergic to reduce spasms and convulsion as well as a cationic oxime capable of removing the OP compounds inside the AChE active site to reactivate the enzyme. In this paper, a theoretical strategy combining docking(MM), chemometric analysis and QM calculations was employed to check out the association and kinetic reactivation coefficients associated to oximes, confronting in vitro the data found in the literature before. The docking results were selected by means of the principal components analysis and submitted to QM calculations. The calculated thermodynamics and kinetics parameters revealed a good correspondence between the calculated intermolecular energy values of the oximes and experimental results, reinforcing the theoretical findings and confirming the theoretical strategy used as a suitable tool for the prediction of kinetic and thermodynamics parameters, which would be able to collaborate with the design of new oximes more effective.

Verified
Journal Article
Open access
PDF file
FSFlávia V. Soares
Flávia V. Soares
ACAlexandre De Castro
Alexandre De Castro
APAnder Pereira
Ander Pereira
DLDaniel Leal
Daniel Leal
DMDaiana T. Mancini
Daiana T. Mancini
Kamil KucaKamil Kuca
Kamil Kuca
Organophosphorus compounds (OP) are part of a group of compounds that may be hazardous to health. They are called neurotoxic agents because of their action on the nervous system, inhibiting the acetylcholinesterase (AChE) enzyme and resulting in a cholinergic crisis. Their high toxicity and rapid action lead to irreversible damage to the nervous system, drawing attention to developing new treatment methods. The diisopropyl fluorophosphatase (DFPase) enzyme has been considered as a potent biocatalyst for the hydrolysis of toxic OP and has potential for bioremediation of this kind of intoxication. In order to investigate the degradation process of the nerve agents Tabun, Cyclosarin and Soman through the wild-type DFPase, and taking into account their stereochemistry, theoretical studies were carried out. The intermolecular interaction energy and other parameters obtained from the molecular docking calculations were used to construct a data matrix, which were posteriorly treated by statistical analyzes of chemometrics, using the PCA (Principal Components Analysis) multivariate analysis. The analyzed parameters seem to be quite important for the reaction mechanisms simulation (QM/MM). Our findings showed that the wild-type DFPase enzyme is stereoselective in hydrolysis, showing promising results for the catalytic degradation of the neurotoxic agents under study, with the degradation mechanism performed through two proposed pathways.

28 September 2018 in Current Alzheimer Research
Verified
Journal Article
Closed access
PDF file
ACAlexandre De Castro
Alexandre De Castro
ECElaine F. F. da Cunha
Elaine F. F. da Cunha
APAnder Pereira
Ander Pereira
FSFlavia V. Soares
Flavia V. Soares
DLDaniel Leal
Daniel Leal
TRTeodorico C. Ramalho
Teodorico C. Ramalho
Introduction: Alzheimer's disease is known to be a chronic disease, with an estimated prevalence of about 10-30%, considering the population over 60 years of age. Most patients with this disorder (> 95%) present the sporadic form, being characterized by a late onset (80-90 years of age), and it is the consequence of the failure to clear the amyloid-β (Aβ) peptide from the interstices of the brain. Significant numbers of genetic risk factors for the sporadic disease have been researched. Some existing drugs for Alzheimer's disease provide symptomatic benefit for up to 12 months, but there are no approved disease- modifying therapies. In this line, a complementary strategy based on repositioning drugs which are approved for the treatment of other disorders could be interesting. It is noteworthy the fact that some clinical trials indicate that several classes of drugs own potent and beneficial effects on the Alzheimer's disease treatment. In this present work, we present the details and evaluation of these alternative treatments. It has highlighted several compounds with relevant evidence for this purpose, which deserves further investigation to clarify optimal treatment conditions in the clinical trials of patients with Alzheimer's disease.

7 June 2016 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
WLWillian E. Amaral de Lima
Willian E. Amaral de Lima
APAnder Pereira
Ander Pereira
ECElaine F.F. da Cunha
Elaine F.F. da Cunha
ZRZoran Radic
Zoran Radic
PTPalmer Taylor
Palmer Taylor
TRTeodorico C. Ramalho
Teodorico C. Ramalho
Butyryl cholinesterase (BChE) has been seen as a key enzyme in the search for new strategies in the treatment of poisoning by organophosphates (OPs), since human BChE (HssBChE), complexed with the appropriate oxime, can be a suitable scavenger and deactivator for OPs in the blood stream. However, the efficacy of HssBChE is limited by its strict stoichiometric scavenging, slow reactivation, and propensity for aging. The improvement of the reactivation rate by new and more efficient oximes could contribute to mitigate this problem and increase the HssBChE efficiency as scavenger. Several oximes have been synthesized and tested with this goal, some with promising results, but the mechanistic aspects of the reactivation reaction are not fully understood yet. In order to better investigate this mechanism, docking and mixed quantum and molecular mechanics combined with principal components analysis were performed here to evaluate the capacity of reactivation and determine the preferred route for the reactivation reaction of two new oximes on HssBChE inhibited by the neurotoxic agents cyclosarin and sarin. Plots of potential energies were calculated and all the transition states of the reactional mechanism were determined. Our results showed a good correlation with experimental data and pointed to the most efficient oxime with both OPs. The protocol used could be a suitable tool for a preliminary evaluation of the HssBChE reactivation rates by new oximes.

1 August 2019 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
APAnder Pereira
Ander Pereira
ACAlexandre De Castro
Alexandre De Castro
FSFlavia Villela Soares
Flavia Villela Soares
DLDaniel Leal
Daniel Leal
ECElaine F.F. da Cunha
Elaine F.F. da Cunha
TRTeodorico C. Ramalho
Teodorico C. Ramalho

9 January 2019 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
ACAlexandre De Castro
Alexandre De Castro
FSFlávia Villela Soares
Flávia Villela Soares
APAnder Pereira
Ander Pereira
TSTelles Cardoso Silva
Telles Cardoso Silva
DSDaniela Rodrigues Silva
Daniela Rodrigues Silva
TRTeodorico C. Ramalho
Teodorico C. Ramalho
Organophosphorus compounds (OP) nerve agents are among the most toxic chemical substances known. Their toxicity is due to their ability to bind to acetylcholinesterase. Currently, some enzymes, such as phosphotriesterase, human serum paraoxonase 1 and diisopropyl fluorophosphatase, capable of degrading OP, have been characterized. Regarding the importance of bioremediation methods for detoxication of OP, this work aims to study the interaction modes between the human human deoxyuridine triphosphate nucleotidohydrolase (dUTPase) and Sarin and VX, considering their Rp and Sp enantiomers, to evaluate the asymmetric catalysis of those compounds. In previous work, this enzyme has shown good potential to degrade phosphotriesters, and based on this characteristic, we have applied the human dUTPase to the OP degradation. Molecular docking, chemometrics and mixed quantum and molecular mechanics calculations have been employed, showing a good interaction between dUTPase and OP. Two possible reaction mechanisms were tested, and according to our theoretical results, the catalytic degradation of OP by dUTPase can take place via both mechanisms, beyond being stereoselective, that is, dUTPase cleaves one enantiomer preferentially in relation to other. Chemometric techniques provided excellent assistance for performing this theoretical investigation. The dUTPase study shows importance by the fact of it being a human enzyme. Communicated by Ramaswamy H. Sarma